NOV Inc (NYSE: NOV) has reported E.P.S. of $0.30 for its first fiscal quarter (ending March 31) versus $0.32 for the same period a year ago. For the latest four quarters through March 31, E.P.S. […]
For its first fiscal quarter (ending March 31), Honeywell International Inc (NASDAQ: HON) has reported E.P.S. of $2.24 compared to $2.09 a year ago. E.P.S. were $8.69 for the latest four quarters through March 31 […]
Gilead Sciences Inc (NASDAQ: GILD) has reported a loss for its first fiscal quarter (ending March 31) of $-3.34 versus $0.81 for the same period a year ago. E.P.S. were $0.40 for the latest four […]
For its first fiscal quarter (ending March 31), Casella Waste Systems Inc (NASDAQ: CWST) has reported E.P.S. of $-0.07 compared to $0.07 a year ago. E.P.S. were $0.31 for the latest four quarters through March […]
Tyler Technologies Inc (NYSE: TYL) has reported E.P.S. of $1.28 for its first fiscal quarter (ending March 31) versus $0.74 for the same period a year ago. For the latest four quarters through March 31, […]
Bunge Ltd (NYSE: BG) has reported earnings for its first fiscal quarter (ending March 31) of $1.68 versus $4.21 for the same period a year ago. For the latest four quarters through March 31, E.P.S. […]
ROLLINS INC (NYSE: ROL) has reported earnings for its first fiscal quarter (ending March 31) of $0.19 versus $0.18 for the same period a year ago. For the latest four quarters through March 31, E.P.S. […]
For its first fiscal quarter (ending March 31), Interpublic Group of Cos Inc (NYSE: IPG) has reported E.P.S. of $0.29 compared to $0.33 a year ago. E.P.S. were $2.83 for the latest four quarters through […]
Humana Inc. (NYSE: HUM) has reported earnings for its first fiscal quarter (ending March 31) of $6.13 versus $9.91 for the same period a year ago. E.P.S. were $16.15 for the latest four quarters through […]
Biogen Inc (NASDAQ: BIIB) has reported earnings for its first fiscal quarter (ending March 31) of $2.71 versus $2.69 for the same period a year ago. For the latest four quarters through March 31, E.P.S. […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research